Non-HDL-apoC-III is an independent predictor of atherosclerosis [15], and LDL containing both apoB and apoC-III is more atherogenic than LDL containing apoB alone [13], supporting an obesity-associated increase in risk attributable to apoC-III. This evidence concerns the gene APOC3 and obesity due to melanocortin 4 receptor deficiency.